1. Home
  2. OLMA vs YRD Comparison

OLMA vs YRD Comparison

Compare OLMA & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • YRD
  • Stock Information
  • Founded
  • OLMA 2006
  • YRD 2012
  • Country
  • OLMA United States
  • YRD China
  • Employees
  • OLMA N/A
  • YRD N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • YRD Finance: Consumer Services
  • Sector
  • OLMA Health Care
  • YRD Finance
  • Exchange
  • OLMA Nasdaq
  • YRD Nasdaq
  • Market Cap
  • OLMA 420.2M
  • YRD 411.2M
  • IPO Year
  • OLMA 2020
  • YRD 2015
  • Fundamental
  • Price
  • OLMA $5.66
  • YRD $4.94
  • Analyst Decision
  • OLMA Strong Buy
  • YRD
  • Analyst Count
  • OLMA 5
  • YRD 0
  • Target Price
  • OLMA $26.25
  • YRD N/A
  • AVG Volume (30 Days)
  • OLMA 1.3M
  • YRD 100.7K
  • Earning Date
  • OLMA 03-10-2025
  • YRD 11-20-2024
  • Dividend Yield
  • OLMA N/A
  • YRD 4.07%
  • EPS Growth
  • OLMA N/A
  • YRD N/A
  • EPS
  • OLMA N/A
  • YRD 2.95
  • Revenue
  • OLMA N/A
  • YRD $802,340,579.00
  • Revenue This Year
  • OLMA N/A
  • YRD N/A
  • Revenue Next Year
  • OLMA N/A
  • YRD N/A
  • P/E Ratio
  • OLMA N/A
  • YRD $1.67
  • Revenue Growth
  • OLMA N/A
  • YRD 19.51
  • 52 Week Low
  • OLMA $4.60
  • YRD $3.89
  • 52 Week High
  • OLMA $16.78
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 41.95
  • YRD 52.12
  • Support Level
  • OLMA $4.60
  • YRD $4.61
  • Resistance Level
  • OLMA $5.83
  • YRD $4.90
  • Average True Range (ATR)
  • OLMA 0.54
  • YRD 0.21
  • MACD
  • OLMA 0.15
  • YRD 0.02
  • Stochastic Oscillator
  • OLMA 59.55
  • YRD 47.80

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: